Skip to main content
SpringerLink
Log in

Conversion therapy of intermediate and advanced hepatocellular carcinoma using superstable homogeneous iodinated formulation technology

  • Insight
  • Published:
Science China Life Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Becker, S., Lepareur, N., Cadeillan, V., Ardisson, V., Bayat, S., Noiret, N., and Garin, E. (2012). Optimization of hepatocarcinoma uptake with radiolabeled lipiodol: development of new lipiodol formulations with increased viscosity. Cancer Biother Radiopharm 27, 149–155.

    CAS  PubMed  Google Scholar 

  • Bzeizi, K.I., Arabi, M., Jamshidi, N., Albenmousa, A., Sanai, F.M., Al-Hamoudi, W., Alghamdi, S., Broering, D., and Alqahtani, S.A. (2021). Conventional transarterial chemoembolization versus drug-eluting beads in patients with hepatocellular carcinoma: a systematic review and meta-analysis. Cancers 13, 6172.

    Article  Google Scholar 

  • Chen, H., Cheng, H., Dai, Q., Cheng, Y., Zhang, Y., Li, D., Sun, Y., Mao, J., Ren, K., Chu, C., et al. (2020a). A superstable homogeneous lipiodol-ICG formulation for locoregional hepatocellular carcinoma treatment. J Control Release 323, 635–643.

    Article  CAS  Google Scholar 

  • Chen, H., Cheng, H., Wu, W., Li, D., Mao, J., Chu, C., and Liu, G. (2020b). The blooming intersection of transcatheter hepatic artery chemoembolization and nanomedicine. Chin Chem Lett 31, 1375–1381.

    Article  CAS  Google Scholar 

  • Cheng, H., Fan, X., Ye, E., Chen, H., Yang, J., Ke, L., You, M., Liu, M., Zhang, Y.W., Wu, Y.L., et al. (2022). Dual tumor microenvironment remodeling by glucose-contained radical copolymer for MRI-guided photoimmunotherapy. Adv Mater 34, 2107674.

    Article  CAS  Google Scholar 

  • Cheng, H., Yang, X., and Liu, G. (2020). Superstable homogeneous iodinated formulation technology: revolutionizing transcatheter arterial chemoembolization. Sci Bull 65, 1685–1687.

    Article  CAS  Google Scholar 

  • Duan, X., Liu, J., Han, X., Ren, J., Li, H., Li, F., and Ju, S. (2021). Comparison of treatment response, survival profiles, as well as safety profiles between Callispheres® microsphere transarterial chemoembolization and conventional transarterial chemoembolization in huge hepatocellular carcinoma. Front Oncol 11, 793581.

    Article  Google Scholar 

  • Fan, X., Ke, L., Cheng, H., Chen, H., Li, Z., Ye, E., Loh, X.J., Wu, Y.L., Liu, G., and Li, Z. (2021). Enhanced drug retention by anthracene crosslinked nanocomposites for bimodal imaging-guided phototherapy. Nanoscale 13, 14713–14722.

    Article  CAS  Google Scholar 

  • Gorodetski, B., Chapiro, J., Schernthaner, R., Duran, R., Lin, M.D., Lee, H., Lenis, D., Stuart, E.A., Nonyane, B.A.S., Pekurovsky, V., et al. (2017). Advanced-stage hepatocellular carcinoma with portal vein thrombosis: conventional versus drug-eluting beads transcatheter arterial chemoembolization. Eur Radiol 27, 526–535.

    Article  Google Scholar 

  • He, P., Ren, E., Chen, B., Chen, H., Cheng, H., Gao, X., Liang, X., Liu, H., Li, J., Li, B., et al. (2022a). A super-stable homogeneous lipiodol-hydrophilic chemodrug formulation for treatment of hepatocellular carcinoma. Theranostics 12, 1769–1782.

    Article  CAS  Google Scholar 

  • He, P., Xiong, Y., Ye, J., Chen, B., Cheng, H., Liu, H., Zheng, Y., Chu, C., Mao, J., Chen, A., et al. (2022b). A clinical trial of super-stable homogeneous lipiodol-nanoICG formulation-guided precise fluorescent laparoscopic hepatocellular carcinoma resection. J Nanobiotechnol 20, 250.

    Article  CAS  Google Scholar 

  • Heaysman, C.L., Philips, G.J., Lloyd, A.W., and Lewis, A.L. (2017). Unusual behaviour induced by phase separation in hydrogel microspheres. Acta Biomater 53, 190–198.

    Article  CAS  Google Scholar 

  • Ji, W., Wu, Q., Han, X., Zhang, W., Wei, W., Chen, L., Li, L., and Huang, W. (2020). Photosensitive hydrogels: from structure, mechanisms, design to bioapplications. Sci China Life Sci 63, 1813–1828.

    Article  Google Scholar 

  • Lee, Y.K., Jung, K.S., Kim, D.Y., Choi, J.Y., Kim, B.K., Kim, S.U., Park, J. Y., Ahn, S.H., Han, K.H., Kim, G.M., et al. (2017). Conventional versus drug-eluting beads chemoembolization for hepatocellular carcinoma: emphasis on the impact of tumor size. J Gastroenterol Hepatol 32, 487–496.

    Article  Google Scholar 

  • Meyer, T., Fox, R., Ma, Y.T., Ross, P.J., James, M.W., Sturgess, R., Stubbs, C., Stocken, D.D., Wall, L., Watkinson, A., et al. (2017). Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial. Lancet Gastroenterol Hepatol 2, 565–575.

    Article  Google Scholar 

  • Omata, M., Cheng, A.L., Kokudo, N., Kudo, M., Lee, J.M., Jia, J., Tateishi, R., Han, K.H., Chawla, Y.K., Shiina, S., et al. (2017). Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int 11, 317–370.

    Article  Google Scholar 

  • Siegel, R.L., Miller, K.D., Fuchs, H.E., and Jemal, A. (2021). Cancer statistics, 2021. CA Cancer J Clin 71, 7–33.

    Article  Google Scholar 

  • Sieghart, W., Hucke, F., and Peck-Radosavljevic, M. (2015). Transarterial chemoembolization: modalities, indication, and patient selection. J Hepatol 62, 1187–1195.

    Article  Google Scholar 

  • Tang, H., Kankala, R.K., Wang, S., and Chen, A. (2019). Supercritical fluid-assisted controllable fabrication of open and highly interconnected porous scaffolds for bone tissue engineering. Sci China Life Sci 62, 1670–1682.

    Article  CAS  Google Scholar 

  • Wang, X., Cui, X., Zhao, Y., and Chen, C. (2020). Nano-bio interactions: the implication of size-dependent biological effects of nanomaterials. Sci China Life Sci 63, 1168–1182.

    Article  CAS  Google Scholar 

  • Wu, B., Zhou, J., Ling, G., Zhu, D., and Long, Q. (2018). CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study. World J Surg Onc 16, 69.

    Article  Google Scholar 

  • Zhang, Y., Cheng, H., Chen, H., Xu, P., Ren, E., Jiang, Y., Li, D., Gao, X., Zheng, Y., He, P., et al. (2022). A pure nanoICG-based homogeneous lipiodol formulation: toward precise surgical navigation of primary liver cancer after long-term transcatheter arterial embolization. Eur J Nucl Med Mol Imag 49, 2605–2617.

    Article  CAS  Google Scholar 

  • Zhu, J., Chu, C., Li, D., Zhang, Y., Cheng, Y., Lin, H., Wang, X., Liu, J., Pang, X., Cheng, J., et al. (2022). Superior fluorescent nanoemulsion illuminates hepatocellular carcinoma for surgical navigation. Front Bioeng Biotechnol 10, 890668.

    Article  Google Scholar 

Download references

Acknowledgements

This work was supported by the Major State Basic Research Development Program of China (2017YFA0205201) and the National Natural Science Foundation of China (81925019, U1705281).

Author information

Author notes

  1. Contributed equally to this work

Authors and Affiliations

  1. State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen, 361102, China

    Zhenjie Li, Hongwei Cheng, Jingsong Mao & Gang Liu

  2. Department of Radiology, Xiang’an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361102, China

    Zhenjie Li & Jingsong Mao

Authors
  1. Zhenjie Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hongwei Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jingsong Mao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gang Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Jingsong Mao or Gang Liu.

Ethics declarations

Compliance and ethics The author(s) declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, Z., Cheng, H., Mao, J. et al. Conversion therapy of intermediate and advanced hepatocellular carcinoma using superstable homogeneous iodinated formulation technology. Sci. China Life Sci. 65, 2114–2117 (2022). https://doi.org/10.1007/s11427-022-2142-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11427-022-2142-3

Search

Navigation